期刊
TOXINS
卷 13, 期 5, 页码 -出版社
MDPI
DOI: 10.3390/toxins13050306
关键词
Shiga toxin; Escherichia coli; hemolytic uremic syndrome; thrombotic microangiopathy
Shiga toxin-producing Escherichia coli-associated hemolytic uremic syndrome (STEC-HUS) historically considered pediatric disease, is characterized by bloody diarrhea, but in adults, the clinical presentation is more diverse and associated with neurological symptoms and a poorer prognosis. There is a need for more studies focused on adult patients to better understand and treat this disease.
Shiga toxin-producing Escherichia coli-associated hemolytic uremic syndrome (STEC-HUS) is a form of thrombotic microangiopathy secondary to an infection by an enterohemorrhagic E. coli. Historically considered a pediatric disease, its presentation has been described as typical, with bloody diarrhea at the forefront. However, in adults, the clinical presentation is more diverse and makes the early diagnosis hazardous. In this review, we review the epidemiology, most important outbreaks, physiopathology, clinical presentation and prognosis of STEC-HUS, focusing on the differential features between pediatric and adult disease. We show that the clinical presentation of STEC-HUS in adults is far from typical and marked by the prevalence of neurological symptoms and a poorer prognosis. Of note, we highlight knowledge gaps and the need for studies dedicated to adult patients. The differences between pediatric and adult patients have implications for the treatment of this disease, which remains a public health threat and lack a specific treatment.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据